An American physician exposed to the Ebola virus in Sierra Leone is expected to be admitted to the National Institutes of Health, officials at the Bethesda-based agency said Saturday in a prepared statement.
As health officials fail to contain West Africa's Ebola outbreak, hospitals in Baltimore and across the U.S. are readying space and equipment for what some consider an inevitability – the arrival of the deadly virus here.
Liberians and Marylanders are vitally connected, and like many Americans, we in Maryland have watched and listened to the graphic daily news stories chronicling Ebola's escalating devastation in Liberia and other West African nations.
The National Institutes of Health has announced the first clinical trial of a vaccine to protect healthy people from infection by the Ebola virus, which is responsible for an estimated 1,550 deaths throughout West Africa.
As the Ebola virus was ravaging West Africa, two American health workers who contracted the disease in Liberia were airlifted back to the United States to be treated with an experimental drug. They are now in Atlanta, recovering.
Public health officials have but one tactic to battle the unrelenting Ebola virus outbreak in West Africa – quarantine – but as the disease nonetheless continues to spread, scientists in Maryland are among those close to discovering other weapons.
State health officials are weighing new safeguards for research laboratories and biotechnology companies that handle potentially deadly infectious pathogens, but whether they will impose any remains a question because they don't know how big a threat there is.